The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
Open accessAbstract
Drug-induced interstitial lung disease (DILD) is not uncommon and has many clinical patterns, ranging from benign infiltrates to life-threatening acute respiratory distress syndrome. There are two mechanisms involved in DILD, which are probably interdependent: one is direct, dose-dependent toxicity and the other is immune-mediated. Cytotoxic lung injury may result from direct injury to pneumocytes or the alveolar capillary endothelium. Drugs can induce all types of immunological reactions described by Gell and Coombs; however, most reactions in immune-mediated DILD may be T cell-mediated. DILD can be difficult to diagnose; diagnosis is often possible by exclusion alone. Identifying the causative drug that induces an allergy or cytotoxicity is essential for preventing secondary reactions. One method to confirm the diagnosis of a drug-induced disease is re-exposure or re-test of the drug. However, clinicians are reluctant to place patients at further risk of illness, particularly in cases with severe drug-induced diseases. Assessment of cell-mediated immunity has recently increased, because verifying the presence or absence of drug-sensitized lymphocytes can aid in confirmation of drug-induced disease. Using peripheral blood samples from drug-allergic patients, the drug-induced lymphocyte stimulation test (DLST) and the leukocyte migration test (LMT) can detect the presence of drug-sensitized T cells. However, these tests do not have a definite role in the diagnosis of DILD. This study explores the potential of these new tests and other similar tests in the diagnosis of DILD and provides a review of the relevant literature on this topic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Clinical Aspects of Immunology.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-1-229_2 · Cited by 1,527
Drug Metabolism and Variability among Patients in Drug Response
Wilkinson, G. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra032424 · Cited by 1,185
The lymphocyte transformation test in the diagnosis of drug hypersensitivity
Pichler, W. J., & Tilch, J. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00547.x · Cited by 657
Druginduced pulmonary disease. Part 1 : Cytotoxic drugs
Cooper, C. (1986) · Medical Entomology and Zoology · Cited by 543
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations
Rossi, S. E., Erasmus, J. J., McAdams, H. P., Sporn, T. A., & Goodman, P. C. (2000) · RadioGraphics · doi:10.1148/radiographics.20.5.g00se081245 · Cited by 449
Interstitial Lung Disease Induced by Drugs and Radiation
Camus, P., Fanton, A., Bonniaud, P., Camus, C., & Foucher, P. (2004) · Respiration · doi:10.1159/000079633 · Cited by 393
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K., & KALOW, W. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-179 · Cited by 373
Drug-induced pulmonary disease
Cooper, J. A. D., & Matthay, R. A. (1987) · Disease-a-Month · doi:10.1016/0011-5029(87)90021-6 · Cited by 297
TAKAHASHI, H., FUJISHIMA, T., KOBA, H., MURAKAMI, S., KUROKAWA, K., SHIBUYA, Y., SHIRATORI, M., KUROKI, Y., & ABE, S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910080 · Cited by 291
Cited by
Yang, H., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00030 · Cited by 280
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses
Baldo, B. (2013) · OncoImmunology · doi:10.4161/onci.26333 · Cited by 191
Metadata
- Authors
- Matsuno, O.
- Venue
- Respiratory Research
- Published
- 2012
- Volume
- 13
- Issue
- 1
- Pages
- 39
- ISSN
- 1465-9921 (ISSN-L)
- OpenAlex
- W2097314218
- Cited by
- 319
- References
- 36
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. https://app.cochat.ai/papers/10.1186/1465-9921-13-39
- The paper
- Matsuno, O. (2012). Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respiratory Research. https://doi.org/10.1186/1465-9921-13-39
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.